Lista de obras -

Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.

artículo científico publicado en 2009

Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution.

artículo científico publicado en 2009

Changes in circulating biomarkers during a single hemodialysis session

artículo científico publicado en 2012

Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease

artículo científico publicado en 2008

Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival

artículo científico publicado en 2011

Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients

artículo científico publicado en 2013

Clinical importance of an elevated circulating chemerin level in incident dialysis patients

artículo científico publicado en 2010

Cytokines

artículo científico publicado en 2012

Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.

artículo científico publicado en 2003

Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects

artículo científico publicado en 2013

Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients

artículo científico publicado en 2010

Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.

artículo científico publicado en 2015

Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?

scientific article published on 01 November 2006

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients

artículo científico publicado en 2008

Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients

artículo científico publicado en 2005

Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats

artículo científico publicado en 2002

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus

artículo científico publicado en 2003

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy

artículo científico publicado en 2004

Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis

scientific article published on 01 July 2007

Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients

artículo científico publicado en 2014

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease

artículo científico publicado en 2005

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.

artículo científico publicado en 2018

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease

artículo científico publicado en 2002

Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).

artículo científico publicado en 2013

Modification of the oxidative stress biomarker AOPP assay: application in uremic samples

artículo científico publicado en 2008

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors

artículo científico publicado en 2007

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

artículo científico publicado en 2014

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation

artículo científico publicado en 2012

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time

artículo científico publicado en 2017

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease

artículo científico publicado en 2016

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients

artículo científico publicado en 2014

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

artículo científico publicado en 2003

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality

artículo científico publicado en 2007

Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients

artículo científico publicado en 2008

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

artículo científico publicado en 2018

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study

scientific article published on 25 September 2018

Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients

artículo científico publicado en 2010

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study

artículo científico publicado en 2018

Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis

artículo científico publicado en 2016

Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease

artículo científico publicado en 2008

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

artículo científico publicado en 2009

Lista de obras de

Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.

Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution.

Changes in circulating biomarkers during a single hemodialysis session

Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease

Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival

Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients

Clinical importance of an elevated circulating chemerin level in incident dialysis patients

Cytokines

Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.

Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects

Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients

Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.

Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients

Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients

Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy

Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis

Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease

Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).

Modification of the oxidative stress biomarker AOPP assay: application in uremic samples

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality

Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study

Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study

Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis

Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.